机译:B7-H3增加了肿瘤相关巨噬细胞的促血管生成功能,并充当三阴性乳腺癌治疗的新型佐剂靶标
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
Peking Univ State Key Lab Prot &
Plant Gene Res Coll Life Sci Beijing 100871 Peoples R China;
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
Nanjing Univ Dept Gen Surg Drum Tower Hosp Sch Med Nanjing 210008 Jiangsu Peoples R China;
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
Nanjing Univ State Key Lab Pharmaceut Biotechnol Nanjing Drum Tower Hosp Affiliated Hosp Med Sch;
TNBC; B7-H3; TAMs; Angiogenesis; Combination cancer therapy;
机译:肿瘤相关巨噬细胞介导的三阴性乳腺癌靶向治疗。
机译:PARP抑制调节BRCA相关乳腺癌中肿瘤相关巨噬细胞(TAMS)的浸润,表型和功能,可以通过利用TAMS的抗肿瘤潜力来增强
机译:磷脂酰综合抗体通过增强免疫激活和下调由T细胞检查点抑制在鼠三重阴性乳腺癌中诱导的促致致因因子来增加抗致致瘤活性的抗致致荷致致致致致致致瘤活性。
机译:装载IR820的PLGA纳米颗粒用于光热疗法治疗三阴性乳腺癌
机译:靶向多异戊二烯基化蛋白功能的三阴性乳腺癌治疗。
机译:肿瘤相关巨噬细胞介导的三阴性乳腺癌靶向治疗。
机译:肿瘤相关的巨噬细胞介导的三重阴性乳腺癌的靶向治疗
机译:针对s1p轴和针对肥胖相关的三阴性乳腺癌的新疗法的开发。